More than 1,800 employees at the Bern facility develop and manufacture innovative biotherapies derived from human plasma.
CSL Behring in Lengnau: Thermo Fisher Scientific and CSL enter strategic partnership
We are proud to work in the field of rare and serious diseases and to provide therapy in many areas of treatment.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people's health.
Every day at CSL Behring, we work as if someone's life depends on it, because it does.
CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions.
Help us deliver our promise to save lives and protect the health of people.
Grow with us: CSL Behring offers university graduates an interesting career as a trainee.
Popular search terms:
The three winners were honored at the graduation ceremony of the University of Bern. (Pictures: Adrian Moser)
BSC Young Boys warmly welcomed Paul McKenzie, CSL's new CEO and Managing Director.
On 28 February 2023 Rare Disease Day will be taking place. #seerare
CSL reported net income after tax of $1.62 billion in the first half of 2023.
The fully automated visual system allows vials to be checked three times faster than the previous process.
CSL scientists are collaborating with research partners in Bern to investigate the biological indicators of sickle cell disea…
Two visits by two Australian Government Officials on two continents within a week.
Pipeline advancements and investment in innovation and disruptive technologies to help fuel sustainable, profitable growth fo…
Seven New CSL Global Research Acceleration Initiative Awardees Announced
We are a biotechnology company, involved for more than a century with research and development related to severe and rare diseases, giving our support to patients with severe diseases.
Join a global biotech leader. We’re ready for you!
Americas
Asia Pacific
Middle East
Europe